Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program. Academic Article uri icon

Overview

abstract

  • This study assesses the outcomes of single-patient use of the US Food and Drug Administration Expanded Access program.

publication date

  • April 1, 2019

Research

keywords

  • Antineoplastic Agents
  • Compassionate Use Trials
  • Drugs, Investigational
  • Neoplasms

Identity

PubMed Central ID

  • PMC6459119

Scopus Document Identifier

  • 85062343497

Digital Object Identifier (DOI)

  • 10.2146/news180048

PubMed ID

  • 30816938

Additional Document Info

volume

  • 5

issue

  • 4